Need for clear inclusion criteria in reviews of antiretroviral treatments
- PMID: 36773625
- DOI: 10.1016/S2352-3018(23)00007-3
Need for clear inclusion criteria in reviews of antiretroviral treatments
Conflict of interest statement
AC received a research grant from Merck Sharp & Dohme and unrestricted education grants from Gilead Sciences, Merck Sharp & Dohme, and Viiv, which were all paid to her institution. GW received an unrestricted research grant from Gilead Sciences paid to his institution and an unrestricted research grant from Roche Diagnostics for laboratory supplies and honoraria paid to his institution by Gilead Sciences and Merck Sharp & Dohme. ME declares no competing interests. AC, GW, and ME are all coauthors of the SIMPL'HIV study.
Comment in
-
Need for clear inclusion criteria in reviews of antiretroviral treatments - Authors' reply.Lancet HIV. 2023 Mar;10(3):e150-e151. doi: 10.1016/S2352-3018(23)00006-1. Epub 2023 Feb 8. Lancet HIV. 2023. PMID: 36773626 Free PMC article. No abstract available.
Comment on
-
Two-drug regimens for HIV treatment.Lancet HIV. 2022 Dec;9(12):e868-e883. doi: 10.1016/S2352-3018(22)00249-1. Epub 2022 Oct 26. Lancet HIV. 2022. PMID: 36309038 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
